To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

HEART FAILURE

TODAY'S HEADLINES

Heart drug improves life expectancy

There is some good news for heart failure patients' life expectancy, in a recent study published in the New England Journal of Medicine. Read more

Cosentyx gets thumbs up for 2 new indications

FDA has approved secukinumab (Cosentyx, Novartis) for the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis. Read more

CONTINUING PHARMACY EDUCATION

LAW: Primer on biosimilar agents

This month's CE activity is open for pharmacists and pharmacy technicians, "LAW: Primer on biosimilar agents." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE law credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

More young white males dying from drug overdoses

Rising death rates for young white adults dying from overdoses make them the first generation since the Vietnam War years of the mid-1960s to experience higher death rates in early adulthood than the generation that preceded it. Details

January 27, 2016

Related Articles

Study: Too many heart failure patients are treated with IV fluids

Secukinumab shows benefit in psoriatic arthritis patients

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us